+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chikungunya Fever - Pipeline Review, H2 2019

  • ID: 4894211
  • Drug Pipelines
  • December 2019
  • Region: Global
  • 122 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Activirosomes Ltd
  • Emergent BioSolutions Inc
  • Hawaii Biotech Inc
  • Indian Immunologicals Ltd
  • Najit Technologies Inc
  • Profectus BioSciences Inc
  • MORE
Chikungunya Fever - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever - Pipeline Review, H2 2019, provides an overview of the Chikungunya Fever (Infectious Disease) pipeline landscape.

Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting and rash and fever. Treatment includes use of NSAIDs.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Chikungunya Fever - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Chikungunya Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 7, 22 and 7 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 6 and 2 molecules, respectively.

Chikungunya Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Chikungunya Fever (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Chikungunya Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Chikungunya Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Chikungunya Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Chikungunya Fever (Infectious Disease)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Chikungunya Fever (Infectious Disease).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Chikungunya Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Activirosomes Ltd
  • Emergent BioSolutions Inc
  • Hawaii Biotech Inc
  • Indian Immunologicals Ltd
  • Najit Technologies Inc
  • Profectus BioSciences Inc
  • MORE
Introduction
Chikungunya Fever - Overview
Chikungunya Fever - Therapeutics Development
Chikungunya Fever - Therapeutics Assessment
Chikungunya Fever - Companies Involved in Therapeutics Development
Chikungunya Fever - Drug Profiles
Chikungunya Fever - Dormant Projects
Chikungunya Fever - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Chikungunya Fever, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Chikungunya Fever - Pipeline by Activirosomes Ltd, H2 2019
Chikungunya Fever - Pipeline by Bharat Biotech Ltd, H2 2019
Chikungunya Fever - Pipeline by Bow Therapeutics, H2 2019
Chikungunya Fever - Pipeline by Ciloa, H2 2019
Chikungunya Fever - Pipeline by Clayton Biotechnologies Inc, H2 2019
Chikungunya Fever - Pipeline by Emergent BioSolutions Inc, H2 2019
Chikungunya Fever - Pipeline by Ennaid Therapeutics LLC, H2 2019
Chikungunya Fever - Pipeline by Etubics Corp, H2 2019
Chikungunya Fever - Pipeline by Globavir Biosciences Inc, H2 2019
Chikungunya Fever - Pipeline by Hawaii Biotech Inc, H2 2019
Chikungunya Fever - Pipeline by HSRx Group, H2 2019
Chikungunya Fever - Pipeline by Immunomodulation Inc, H2 2019
Chikungunya Fever - Pipeline by Imophoron Ltd, H2 2019
Chikungunya Fever - Pipeline by Indian Immunologicals Ltd, H2 2019
Chikungunya Fever - Pipeline by Inovio Pharmaceuticals Inc, H2 2019
Chikungunya Fever - Pipeline by Integral Molecular Inc, H2 2019
Chikungunya Fever - Pipeline by Integrated BioTherapeutics Inc, H2 2019
Chikungunya Fever - Pipeline by Medigen Inc, H2 2019
Chikungunya Fever - Pipeline by Moderna Therapeutics Inc, H2 2019
Chikungunya Fever - Pipeline by Najit Technologies Inc, H2 2019
Chikungunya Fever - Pipeline by Pai Life Sciences Inc, H2 2019
Chikungunya Fever - Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2019
Chikungunya Fever - Pipeline by Plant Bioscience Ltd, H2 2019
Chikungunya Fever - Pipeline by Precision Virologics Inc, H2 2019
Chikungunya Fever - Pipeline by Profectus BioSciences Inc, H2 2019
Chikungunya Fever - Pipeline by Quratis Inc, H2 2019
Chikungunya Fever - Pipeline by Riboscience LLC, H2 2019
Chikungunya Fever - Pipeline by Sementis Ltd, H2 2019
Chikungunya Fever - Pipeline by Shionogi & Co Ltd, H2 2019
Chikungunya Fever - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2019
Chikungunya Fever - Pipeline by Themis Bioscience GmbH, H2 2019
Chikungunya Fever - Pipeline by Valneva SE, H2 2019
Chikungunya Fever - Pipeline by Vaxart Inc, H2 2019
Chikungunya Fever - Pipeline by VenatoRx Pharmaceuticals Inc, H2 2019
Chikungunya Fever - Dormant Projects, H2 2019
Chikungunya Fever - Dormant Projects, H2 2019 (Contd..1), H2 2019

List of Figures
Number of Products under Development for Chikungunya Fever, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Activirosomes Ltd
  • Bharat Biotech Ltd
  • Bow Therapeutics
  • Ciloa
  • Clayton Biotechnologies Inc
  • Emergent BioSolutions Inc
  • Ennaid Therapeutics LLC
  • Etubics Corp
  • Globavir Biosciences Inc
  • Hawaii Biotech Inc
  • HSRx Group
  • Immunomodulation Inc
  • Imophoron Ltd
  • Indian Immunologicals Ltd
  • Inovio Pharmaceuticals Inc
  • Integral Molecular Inc
  • Integrated BioTherapeutics Inc
  • Medigen Inc
  • Moderna Therapeutics Inc
  • Najit Technologies Inc
  • Pai Life Sciences Inc
  • Paradigm Biopharmaceuticals Ltd
  • Plant Bioscience Ltd
  • Precision Virologics Inc
  • Profectus BioSciences Inc
  • Quratis Inc
  • Riboscience LLC
  • Sementis Ltd
  • Shionogi & Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Themis Bioscience GmbH
  • Valneva SE
  • Vaxart Inc
  • VenatoRx Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll